164 related articles for article (PubMed ID: 30734715)
1. Is the high risk of anaphylaxis to omalizumab a contraindication to this treatment?
Tiotiu A; Poreaux C; Poncet P; Senechal H; Schmutz JL
Eur J Dermatol; 2019 Feb; 29(1):101-102. PubMed ID: 30734715
[No Abstract] [Full Text] [Related]
2. Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab.
Prieto-García A; Noguerado B; Rojas P; Torrado I; Rodríguez-Fernández A; Tornero P
J Investig Allergol Clin Immunol; 2019 Feb; 29(1):53-55. PubMed ID: 30785102
[No Abstract] [Full Text] [Related]
3. Atopic dermatitis is an important comorbidity in severe asthma.
Lee JK; Han D
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):661-662. PubMed ID: 29496463
[No Abstract] [Full Text] [Related]
4. Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis.
Wang HH; Li YC; Huang YC
J Allergy Clin Immunol; 2016 Dec; 138(6):1719-1722.e1. PubMed ID: 27543070
[No Abstract] [Full Text] [Related]
5. Comparing the Roles of Omalizumab and UV Therapy in Treating Severe Pediatric Atopic Dermatitis-Reply.
Chan S; Lack G
JAMA Pediatr; 2021 Feb; 175(2):206. PubMed ID: 32539090
[No Abstract] [Full Text] [Related]
6. Anaphylactic reactions associated with omalizumab administration: Analysis of a case-control study.
Lieberman PL; Umetsu DT; Carrigan GJ; Rahmaoui A
J Allergy Clin Immunol; 2016 Sep; 138(3):913-915.e2. PubMed ID: 27236498
[No Abstract] [Full Text] [Related]
7. Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis.
Incorvaia C; Pravettoni C; Mauro M; Yacoub MR; Tarantini F; Riario-Sforza GG
Monaldi Arch Chest Dis; 2008 Jun; 69(2):78-80. PubMed ID: 18837422
[TBL] [Abstract][Full Text] [Related]
8. Omalizumab may facilitate drug desensitization in patients failing standard protocols.
Gemici Karaaslan HB; Karabag Yilmaz E; Gulmez R; Canpolat N; Kiykim A; Cokugras HC
Pediatr Allergy Immunol; 2022 May; 33(5):e13783. PubMed ID: 35616895
[No Abstract] [Full Text] [Related]
9. Omalizumab efficacy in a girl with atopic eczema.
Caruso C; Gaeta F; Valluzzi RL; Romano A
Allergy; 2010 Feb; 65(2):278-9. PubMed ID: 19796201
[No Abstract] [Full Text] [Related]
10. IgE-Related Chronic Diseases and Anti-IgE-Based Treatments.
Navinés-Ferrer A; Serrano-Candelas E; Molina-Molina GJ; Martín M
J Immunol Res; 2016; 2016():8163803. PubMed ID: 28097159
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of omalizumab in paediatric age: an update of literature data.
Matin N; Tabatabaie O; Falsaperla R; Pavone P; Serra A; Cocuzza S; Di Mauro P; Licciardello L; Lubrano R; Vitaliti G
J Biol Regul Homeost Agents; 2016; 30(2):579-84. PubMed ID: 27358151
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of omalizumab in the treatment of atopic dermatitis: a pilot study.
Sheinkopf LE; Rafi AW; Do LT; Katz RM; Klaustermeyer WB
Allergy Asthma Proc; 2008; 29(5):530-7. PubMed ID: 18926061
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of severe recalcitrant vernal keratoconjunctivitis and atopic dermatitis associated with elevated IgE levels with omalizumab.
Zengarini C; Roda M; Schiavi C; Bruni F; Bardazzi F; Bellusci C; Raone B
Clin Exp Dermatol; 2022 Mar; 47(3):604-606. PubMed ID: 34731495
[TBL] [Abstract][Full Text] [Related]
14. Characterization of an anaphylactoid reaction to omalizumab.
Dreyfus DH; Randolph CC
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):624-7. PubMed ID: 16680936
[TBL] [Abstract][Full Text] [Related]
15. [Dermatological implications of omalizumab, an anti-IgE antibody].
Di Lucca-Chrisment J
Rev Med Suisse; 2015 Apr; 11(468):779-80, 782-3. PubMed ID: 26021140
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab therapy in a patient with cronic spontaneous urticaria, ulcerative colitis, hypereosinophilia and prurigo Besnier: a case report.
Grieco T; Chello C; Faina V; Gomes VV; Alei L; Sernicola A; Panasiti V; Calvieri S
J Dermatolog Treat; 2018; 29(sup3):10-13. PubMed ID: 30256692
[TBL] [Abstract][Full Text] [Related]
17. Omalizumab for atopic dermatitis: case series and a systematic review of the literature.
Holm JG; Agner T; Sand C; Thomsen SF
Int J Dermatol; 2017 Jan; 56(1):18-26. PubMed ID: 27337170
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab as an adjuvant therapy for treating severe atopic dermatitis in children. A serie of cases.
García M; Durán-Crane A; Chapman E; García E
Rev Alerg Mex; 2019; 66(3):282-291. PubMed ID: 31606011
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Roles of Omalizumab and Ultraviolet Therapy in Treating Severe Pediatric Atopic Dermatitis.
Park J
JAMA Pediatr; 2021 Feb; 175(2):205. PubMed ID: 32539105
[No Abstract] [Full Text] [Related]
20. Omalizumab in children with severe allergic disease: a case series.
Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
